The invention relates to the field of chemical and pharmaceutical industry, specifically to a pharmaceutical composition for the treatment of HIV infection； it contains at least one HIV protease inhibitor as an active ingredient, as well as pharmaceutically acceptable excipients with a specific quantitative component ratio. Additionally, the invention belongs to the process of its production and to a treatment method. Pharmaceutical composition according to the invention has increased bioavailability and improved technological properties compared to the prototype drug.
